INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2007

Only about one-third to one-half of people can convert the soy isoflavone daidzein into equol via intestinal microflora.

Soy isoflavones are linked to lower rates of cardiovascular disease, osteoporosis, and some cancers. Clinical efficacy may rely on biotransforming daidzein into equol, a metabolite with greater estrogen receptor affinity, antiandrogenic properties, and superior antioxidant activity. Only about one-third to one-half of the population can produce equol, likely due to interindividual variations in gut microflora, though specific bacterial species responsible remain to be identified.

Shows an association, not proof of cause and effect.

Study type
Narrative review
Who was studied
Human population consuming soy isoflavones
What was measured
Equol production from daidzein and related health implications

THE PAPER

Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health.

Yuan JP, Wang JH, Liu X. Mol Nutr Food Res, 2007.

PubMed 17579894 ↗DOI 10.1002/mnfr.200600262 ↗

Heart & arteriesCancerGut & microbiomeBones & muscles

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.